Photo from wikipedia
Patients (pts) with cardiomyopathy (CM) and impaired ejection fraction (EF) have increased risk of ventricular tachycardia or fibrillation (VT/VF). The wearable cardioverter defibrillator (WCD) protects pts with VT/VF until their… Click to show full abstract
Patients (pts) with cardiomyopathy (CM) and impaired ejection fraction (EF) have increased risk of ventricular tachycardia or fibrillation (VT/VF). The wearable cardioverter defibrillator (WCD) protects pts with VT/VF until their response to guideline directed medical therapy (GDMT) can be
Keywords:
ejection fraction;
cardioverter defibrillator;
wearable cardioverter
Journal Title: JACC: Clinical Electrophysiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JACC: Clinical Electrophysiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!